How to buy Polarityte stock (PTE)

Polarityte is a biotechnology & medical research business based in the US. Polarityte shares (PTE) are listed on the NASDAQ and all prices are listed in US Dollars. Polarityte employs 42 staff and has a trailing 12-month revenue of around $73,000.

Our top picks for where to buy Polarityte stock

Buy Polarityte stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Polarityte stock price (NASDAQ: PTE)

Use our graph to track the performance of PTE stocks over time.

Polarityte shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$0.35
200-day moving average more info button	$0.62
Wall St. target price	$0.80
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-0.58

Is it a good time to buy Polarityte stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Polarityte financials

Revenue TTM	$73,000
Gross profit TTM	$198,000
Return on assets TTM	-56.67%
Return on equity TTM	-54.97%
Profit margin	0%
Book value	$1.74
Market Capitalization more info button	$1.8 million

TTM: trailing 12 months

Polarityte share dividends

We're not expecting Polarityte to pay a dividend over the next 12 months.

Have Polarityte's shares ever split?

Polarityte's shares were split on a 1:25 basis on 16 May 2022 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Polarityte shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Polarityte shares which in turn could have impacted Polarityte's share price.

Polarityte share price volatility

Over the last 12 months, Polarityte's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Polarityte's is 1.1518. This would suggest that Polarityte's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Polarityte overview

PolarityTE, Inc. , a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Frequently asked questions

What percentage of Polarityte is owned by insiders or institutions?
Currently 3.427% of Polarityte shares are held by insiders and 9.385% by institutions. How many people work for Polarityte?
Latest data suggests 42 work at Polarityte. When does the fiscal year end for Polarityte?
Polarityte's fiscal year ends in December. Where is Polarityte based?
Polarityte's address is: 1960 South 4250 West, Salt Lake City, UT, United States, 84104 What is Polarityte's ISIN number?
Polarityte's international securities identification number is: US7310941080 What is Polarityte's CUSIP number?
Polarityte's Committee on Uniform Securities Identification Procedures number is: 560690109